Skip to content

Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant

Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03458897
Enrollment
7
Registered
2018-03-08
Start date
2018-05-03
Completion date
2020-09-01
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

bone marrow cellularity, bone marrow transplant

Brief summary

The primary purpose of this research is to determine if it is feasible to perform serial magnetic resonance imaging (MRI) to evaluate the amount of bone marrow cells (also called cellularity) and iron stores before and after bone marrow transplantation for severe sickle cell disease.

Interventions

DIAGNOSTIC_TESTserial functional magnetic resonance imaging (MRI)

All subjects with sickle cell disease undergoing bone marrow transplantation will undergo up to 4 functional MRI scans.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 5 years. * Diagnosis of SCD (\[Hemoglobin SS (Hb-SS), Hemoglobin SC (Hb-SC) or Hemoglobin S-Beta thalassemia (Hb-Sβ) genotype\]. * Patient is a candidate for an allogeneic HCT. * Subject or guardians have given informed consent.

Exclusion criteria

* The need for general anesthesia for MRI. * Subjects with implanted magnetic devices (e.g. pacemakers) that may malfunction or move in the strong magnetic field. * A subject who is pregnant. * Previous HCT.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of obtaining serial scans in patients with sickle cell undergoing marrow transplant110 days post transplantFeasibility will be measured by the number of subjects who undergo at least 2 of 4 scheduled functional MRI's

Secondary

MeasureTime frameDescription
MRI and hemoglobin S.1 year post transplantCorrelation between functional MRI result and hemoglobin S level.
MRI and neutrophil engraftment1 year post transplantCorrelation between functional MRI result and time to neutrophil engraftment
MRI and chimerism1 year post transplantCorrelation between functional MRI result and time to donor/ recipient chimerism

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026